Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital.

Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Photo courtesy of Thorsten Mohr/Saarland University

News | Prostate Cancer | November 28, 2019
Radiation Therapy Effective in Patients with No Further Treatment Options
November 28, 2019 — Reports of new cancer treatments often raise high hopes and expectations, particularly, of course,...
read more
Prostate cancer MRI
News | Clinical Trials | November 15, 2019
Theragnostics Reports Positive Clinical Trial Results from Prostate Cancer Study
November 15, 2019 — Theragnostics, which is developing innovative radiopharmaceuticals to improve cancer diagnosis and...
read more
GE Healthcare and Theragnostics Partnering on PSMA PET/CT Imaging Agent
News | Prostate Cancer | October 16, 2019
GE Healthcare and Theragnostics Partnering on PSMA PET/CT Imaging Agent
October 16, 2019 — GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate...
read more
Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Feature | Prostate Cancer | October 16, 2019 | By Jeff Zagoudis
Advances in Prostate Cancer Radiotherapy
Radiation therapy is an important tool in the clinician’s armamentarium for treatment of localized, early-stage...
read more
Videos | Prostate Cancer | September 30, 2019
VIDEO: Use of Hydrogel to Reduce Rectal Toxicity for Prostate Radiotherapy
Bill Hartsell, M.D., medical director of the Northwestern Medicine Proton Center in Warrenville, Ill., discusses the...
read more
High-dose Radiation Effective for Men Whose Prostate Cancer Has Spread
News | Prostate Cancer | September 23, 2019
High-dose Radiation Effective for Men Whose Prostate Cancer Has Spread
September 23, 2019 — A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate...
read more
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
News | Prostate Cancer | September 16, 2019
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
September 16, 2019 — Secondary analysis of a recent clinical trial that changed the standard of care for men with...
read more
Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting
News | Brachytherapy Systems | September 13, 2019
Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting
September 13, 2019 — Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131...
read more
The irregularly marginated left tumor mass that bulges the lateral capsule appears three times the volume on the multiplanar 3-D/4-D image reconstruction and shows complete extraprostatic extension

Figure 1. 2-D (top) vs 3-D (bottom). The irregularly marginated left tumor mass that bulges the lateral capsule appears three times the volume on the multiplanar 3-D/4-D image reconstruction and shows complete extraprostatic extension. Note: This anterolateral lesion is not clinically palpable.

Feature | Prostate Cancer | September 05, 2019 | By Robert Bard, M.D., DABR, FASLM
4-D Guided Prostate Treatment: The Future of OIM-directed Therapies
Extracapsular extension (ECE) is a major clinical indicator for brachytherapy or external beam treatment of prostate...
read more
Surging Demand for Image-guided, Stereotactic Radiation Therapy Driving Fiducial Marker Growth
News | Radiation Therapy | August 22, 2019
Surging Demand for Image-guided, Stereotactic Radiation Therapy Driving Fiducial Marker Growth
August 22, 2019 — As fiducial markers gain traction in parallel to rising incidences of various cancer affecting lung,...
read more
Videos | Treatment Planning | August 21, 2019
VIDEO: Artificial Intelligence Automatic Contouring and Segmentation For Radiotherapy
This is an example of the Mirada DLCExpert deep learning software that automatically identifies organs, segments and...
read more
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
August 20, 2019 — According to the American Cancer Society, approximately one in nine men will be diagnosed with...
read more
MRIdian System Limits Early Toxicity for Prostate Cancer Without Implanted Markers
News | Image Guided Radiation Therapy (IGRT) | August 19, 2019
MRIdian System Limits Early Toxicity for Prostate Cancer Without Implanted Markers
August 19, 2019 — ViewRay Inc. announced the acceptance of publication by the International Journal of Radiation...
read more
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
August 16, 2019 — Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug...
read more
Efficacy of Isoray's Cesium Blu Showcased in Recent Studies
News | Brachytherapy Systems | August 14, 2019
Efficacy of Isoray's Cesium Blu Showcased in Recent Studies
August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medical...
read more
Progenics Pharmaceuticals Collaborating With Veterans Affairs on AI Research Program
News | Artificial Intelligence | July 26, 2019
Progenics Pharmaceuticals Collaborating With Veterans Affairs on AI Cancer Imaging Research Program
July 26, 2019 — Oncology company Progenics Pharmaceuticals Inc. announced their collaboration with the Veterans Affairs...
read more
Videos | Artificial Intelligence | July 22, 2019
VIDEO: Use of Machine Learning to Automate Radiotherapy Treatment Planning
Leigh Conroy, Ph.D., physics resident, University Health Network, Princess Margaret Cancer Center, Toronto, Canada,...
read more
Shorter Courses of Proton Therapy Equally Effective in Treating Prostate Cancer
News | Proton Therapy | July 17, 2019
Shorter Courses of Proton Therapy Equally Effective in Treating Prostate Cancer
July 17, 2019 — Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to...
read more
Bracco Imaging Acquires Blue Earth Diagnostics
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging Acquires Blue Earth Diagnostics
July 1, 2019 — Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular...
read more
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
June 17, 2019 — A new study reveals black men are less likely than white men to adopt an active surveillance strategy...
read more
© Copyright Wainscot Media. All Rights Reserved.